CORRECTED: Peregrine Ventures sells part of its investment in Neovasc
Israeli venture capital firm Peregrine Ventures recently sold about 28.2 percent of its shares in Neovasc Inc (TSX: NVC), a Canadian specialty medical device company that develops products for the cardiovascular market. The investment stake in the company was acquired by Fidelity Investments for US$12 million. Peregrine retains more than 71 percent of its holdings in Neovasc, which was previously known as Medical Ventures Corp. In 2008, the latter company acquired Neovasc Medical Ltd and B-Balloon Ltd, two portfolio companies of Peregrine.
3 November 2014•2 mins read
